Application value of left approach descending hepatic portal plate combined with Glisson pedicle transection hepatectomy in liver tumors
Objective To explore the application value of left approach descending hepatic portal plate combined with Glisson pedicle transection hepatectomy in liver tumors.Methods A total of 126 patients who underwent liver tumors surgery in our hospital from June 2018 to June 2022 were selected as the research objects.According to different surgical methods,the patients were divided into experimental group(68 cases,left approach descending hepatic portal plate combined with Glisson pedicle transection hepatectomy)and control group(58 cases,traditional anatomical hepatectomy).The intraoperative blood loss,operation time,liver function indexes,postoperative complications and survival were compared between the two groups.Results The intraoperative blood loss in the experimental group was less than that in the control group(P<0.05);there was no significant difference in the operation time between the two groups(P>0.05).At 3,7 d after operation,the levels of aspartate transaminase(AST)and alanine aminotransferase(ALT)in the experimental group were lower than those in the control group(P<0.05).The total incidence of postoperative complications in the experimental group was lower than that in the control group(P<0.05).The long-term median survival time of the experimental group and the control group was 22.0 months and 17.0 months,respectively,and the difference was not statistically significant(P=0.057);the median tumor-free survival time of the experimental group and the control group was 20.0 months and 17.0 months,respectively,and the difference was not statistically significant(P=0.187).Conclusion The left approach descending hepatic portal plate combined with Glisson pedicle transection hepatectomy has the advantages of less bleeding and less liver injury,it is a safe,effective and feasible surgical method for the treatment of liver tumors.